- Investing Ideas
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
98
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
98 companies
Protagonist Therapeutics
Market Cap: US$6.7b
Operates as a discovery and development company in the United States.
PTGX
US$102.17
7D
0.5%
1Y
106.7%
Inovio Pharmaceuticals
Market Cap: US$106.4m
A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
INO
US$1.55
7D
-6.1%
1Y
-11.9%
Celcuity
Market Cap: US$5.1b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$114.81
7D
1.6%
1Y
989.3%
Prothena
Market Cap: US$501.2m
A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.
PRTA
US$9.52
7D
11.5%
1Y
-26.8%
Geron
Market Cap: US$1.0b
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.54
7D
-0.6%
1Y
-6.7%
Tonix Pharmaceuticals Holding
Market Cap: US$201.1m
A fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States.
TNXP
US$13.75
7D
-12.8%
1Y
-48.4%
Sangamo Therapeutics
Market Cap: US$130.6m
A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
SGMO
US$0.34
7D
0.9%
1Y
-59.9%
Legend Biotech
Market Cap: US$3.3b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$17.49
7D
-2.1%
1Y
-50.6%
Shenzhen Kangtai Biological Products
Market Cap: CN¥15.0b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥13.45
7D
-5.1%
1Y
-14.0%
Takara Bio
Market Cap: JP¥138.2b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥1,148.00
7D
0.09%
1Y
32.4%
Medivir
Market Cap: SEK 1.3b
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Sweden, the Nordic region, rest of Europe, and internationally.
MVIR
SEK 2.44
7D
6.3%
1Y
78.1%
FluoGuide
Market Cap: SEK 642.5m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 38.20
7D
1.6%
1Y
0.5%
Caris Life Sciences
Market Cap: US$5.2b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$18.33
7D
-2.6%
1Y
n/a
Heron Therapeutics
Market Cap: US$150.1m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$0.83
7D
1.0%
1Y
-64.3%
CareDx
Market Cap: US$894.7m
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$17.47
7D
-0.7%
1Y
-4.8%
Duality Biotherapeutics
Market Cap: HK$23.1b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$256.00
7D
-9.9%
1Y
n/a
Immunocore Holdings
Market Cap: US$1.5b
Engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.
IMCR
US$30.51
7D
1.6%
1Y
1.3%
Vitrolife
Market Cap: SEK 12.6b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 92.85
7D
5.6%
1Y
-42.4%
Aroa Biosurgery
Market Cap: AU$196.9m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.57
7D
-0.9%
1Y
21.3%
SynAct Pharma
Market Cap: SEK 966.6m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 17.32
7D
-1.0%
1Y
9.7%
Candel Therapeutics
Market Cap: US$365.5m
A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.
CADL
US$4.88
7D
-0.6%
1Y
-29.8%
Genfit
Market Cap: €423.3m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€8.50
7D
-6.6%
1Y
153.7%
Zymeworks
Market Cap: US$1.8b
A biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
ZYME
US$24.69
7D
3.3%
1Y
97.4%
Protalix BioTherapeutics
Market Cap: US$174.0m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.11
7D
-5.4%
1Y
-18.2%
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$196.15
7D
-3.2%
1Y
32.3%
Poltreg
Market Cap: zł92.8m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.90
7D
-17.1%
1Y
-44.4%